Cue Biopharma, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Cue Biopharma, Inc. quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q3 2023.
  • Cue Biopharma, Inc. Operating Lease, Payments for the quarter ending September 30, 2023 was $709K, a 139% increase year-over-year.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $709K +$412K +139% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $702K +$602K +602% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $652K +$557K +586% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q3 2022 $297K -$988K -76.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $100K -$1.19M -92.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $95K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $1.29M +$116K +9.92% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.29M +$392K +43.9% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-09
Q3 2020 $1.17M +$276K +30.9% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $893K Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $1.17M +$418K +55.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q3 2019 $893K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-07
Q1 2019 $756K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.